FTC Loses Assault On Shire Unit's Serial FDA Petitions

The Federal Trade Commission on Tuesday lost its first-ever legal assault on drugmaker efforts to delay generic competition by constantly petitioning the U.S. Food and Drug Administration, even as a Delaware...

Already a subscriber? Click here to view full article